ArQule (ARQL) News Today

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	Merck Sharp & Dohme Corp.'s Net Worth benzinga.com - March 22 at 9:14 PM
	ASCO Live Blog: Saturday thestreet.com - June 30 at 8:18 PM
	2023 Fibroblast Growth Factor Receptor 2 Inhibitor Market Share and Growth Rate Forecast for 2030 marketwatch.com - May 5 at 10:47 AM
	Welcome to My Portfolio - Link your brokers or add lots finance.yahoo.com - April 3 at 12:11 AM
	40+ Key Companies Actively Working in the Marginal Zone Lymphoma Pipeline Segment \| DelveInsight - GlobeNewswire globenewswire.com - September 21 at 6:03 PM
	Form SC 13E3 Stealth BioTherapeutics Filed by: Stealth BioTherapeutics Corp - StreetInsider.com streetinsider.com - August 21 at 10:47 PM
	Merus Stock: Precision Oncology Pioneer Executes In The Clinic (NASDAQ:MRUS) - Seeking Alpha seekingalpha.com - June 30 at 12:05 PM
	Aptose Reports Results for the First Quarter 2022 - GuruFocus.com gurufocus.com - June 18 at 6:41 PM
	Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - May 9 at 10:07 PM
	RENEWABLE ENERGY GROUP, INC. : Other Events (form 8-K) - Marketscreener.com marketscreener.com - May 9 at 5:06 PM
	Aptose Reports Results for the First Quarter 2022 - Financial Post financialpost.com - May 9 at 5:06 PM
	Form DEF 14A Deciphera Pharmaceutical For: Jun 23 - StreetInsider.com streetinsider.com - April 26 at 1:57 PM
	Basilea reports preclinical data on oncology drug candidates BAL0891, derazantinib and lisavanbulin at AACR Annual Meeting - GlobeNewswire globenewswire.com - April 13 at 2:43 AM
	APTOSE BIOSCIENCES INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com marketscreener.com - April 11 at 8:39 PM
	Aptose Announces Executive Management Changes - StreetInsider.com streetinsider.com - April 8 at 6:42 PM
	West Pharmaceutical Services : Names President and CEO Eric M. Green as Chair of the Board - Form 8-K - marketscreener.com marketscreener.com - March 1 at 5:03 AM
	West Names President and CEO Eric M. Green as Chair of the Board - PRNewswire prnewswire.com - February 28 at 4:49 PM
	Basilea to become a leading anti-infectives company backed - GlobeNewswire globenewswire.com - February 15 at 1:47 AM
	HeartFlow Appoints Timothy Barabe to its Board of Directors - StreetInsider.com streetinsider.com - January 20 at 9:32 AM
	HeartFlow Appoints Timothy Barabe to its Board of Directors - Yahoo Finance finance.yahoo.com - January 18 at 8:49 PM
	Basilea reports on portfolio progress made in 2021 - GlobeNewswire globenewswire.com - January 6 at 9:53 AM
	Curis Adds Three New Executives to Management Team Strengthening Medical Affairs, Clinical Development and Clinical Operations - marketscreener.com marketscreener.com - January 3 at 8:08 AM
	SAVA Stock: 8 Things to Know as Cassava Sciences Rockets Higher - InvestorPlace investorplace.com - November 2 at 5:41 PM
	Basilea presents preclinical data on synergy between derazantinib and paclitaxel in gastric tumor models at ANE Conference - Yahoo Finance finance.yahoo.com - October 11 at 1:27 AM
	Enlivex Therapeutics : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS ON (Form 6-K) - Marketscreener.com marketscreener.com - September 30 at 10:10 PM
	Form 6-K Enlivex Therapeutics For: Sep 30 - StreetInsider.com streetinsider.com - September 30 at 10:10 PM
	Merck & Co., Inc. (MRK) Management Presents at European Society for Medical Oncology Virtual Congress 2021 (Transcript) - Seeking Alpha seekingalpha.com - September 21 at 3:57 AM
	Basilea presents full safety and efficacy data set on derazantinib in patients with FGFR2 fusion-positive iCCA at ESMO congress - StreetInsider.com streetinsider.com - September 18 at 6:38 PM
	Basilea presents full safety and efficacy data set on derazantinib in patients with FGFR2 fusion-positive iCCA at ESMO congress - Yahoo Finance UK uk.finance.yahoo.com - September 17 at 5:35 PM
	Basilea presents full safety and efficacy data set on derazantinib in patients with FGFR2 fusion-positive iCCA at ESMO congress - Yahoo Finance finance.yahoo.com - September 17 at 12:34 PM
	Basilea presents full safety and efficacy data set on derazantinib in patients with FGFR2 fusion-positive - Benzinga benzinga.com - September 17 at 2:08 AM
	Merck & Co., Inc. (MRK) CEO Robert Davis Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript) - Seeking Alpha seekingalpha.com - September 13 at 5:42 PM
	Infinity Pharma Names Robert Ilaria As CMO And Brian Schwartz To Board - Quick Facts - Nasdaq nasdaq.com - September 7 at 4:55 PM
	Infinity Pharma (INFI) Appoints Robert Ilaria as Chief Medical Officer; Brian Schwartz to its Board - StreetInsider.com streetinsider.com - September 7 at 8:33 AM
	Basilea reports strong financial results for half-year 2021 - GlobeNewswire globenewswire.com - August 17 at 3:57 AM
	Press Release : Basilea reports strong financial -3- - Marketscreener.com marketscreener.com - August 17 at 3:57 AM

Get ArQule News Delivered to You Automatically

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ARQL Media Mentions By Week

ARQL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARQL
News Sentiment
▼
0.00

0.53
▲
Average
Medical
News Sentiment

ARQL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARQL Articles
This Week
▼
0

0
▲
ARQL Articles
Average Week

Get ArQule News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ARQL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ArQule (ARQL) News Today

ARQL Media Mentions By Week

ARQL Media Sentiment

ARQL News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info